(S (NP-SBJ (JJ Human) (NN T) (NN cell) (NN transcription) (NN factor) (NN GATA-3)) (VP (VBZ stimulates) (NP (NN HIV-1) (NN expression))) (. .))
(S (NP-SBJ-17 (NP (NP (DT A) (NN family)) (PP (IN of) (NP (JJ transcriptional) (VBG activating) (NNS proteins)))) (, ,) (NP (DT the) (NN GATA) (NNS factors)) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ (-NONE- *-17)) (VP (TO to) (VP (VB bind) (PP (TO to) (NP (DT a) (NN consensus) (NN motif))) (PP (IN through) (NP (DT a) (ADJP (RB highly) (VBN conserved)) (NN C4) (NN zinc) (NN finger) (NN DNA) (NN binding) (NN domain))))))))) (. .))
(S (NP-SBJ-18 (NP (NP (CD One) (NN member)) (PP (IN of) (NP (DT this) (JJ multigene) (NN family)))) (, ,) (NP (NN GATA-3)) (, ,)) (VP (VBZ is) (ADVP-PRD (RBS most) (RB abundantly)) (VP (VBN expressed) (NP (-NONE- *-18)) (PP (IN in) (NP (NP (NN T) (NNS lymphocytes)) (, ,) (NP (NP (DT a) (JJ cellular) (NN target)) (PP (IN for) (NP (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))) (NP-COOD (NP (NN infection)) (CC and) (NP (NN replication)))))))))) (. .))
(S (NP-SBJ (ADJP (FW In) (FW vitro)) (NN DNase) (CD I) (NN footprinting) (NN analysis)) (VP (VBD revealed) (NP (NP (CD six) (NN hGATA-3) (NN binding) (NNS sites)) (PP (IN in) (NP (NP (NP (DT the) (NN U3) (NN region)) (PRN (-LRB- -LRB-) (NP (DT the) (ADJP (JJ transcriptional) (JJ regulatory)) (NN domain)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN HIV-1) (NN LTR))))))) (. .))
(S-COOD (S (NP-SBJ (NP (NN Cotransfection)) (PP (IN of) (NP (DT an) (NN hGATA-3) (NN expression) (NN plasmid))) (PP (IN with) (NP (NP (DT a) (NN reporter) (NN plasmid)) (SBAR (WHNP-19 (WP$ whose) (NN transcription)) (S (NP-SBJ-20 (-NONE- *T*-19)) (VP (VBZ is) (VP (VBN directed) (NP (-NONE- *-20)) (PP (IN by) (NP-LGS (DT the) (NN HIV-1) (NN LTR)))))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (QP (CD 6-) (TO to) (JJ 10-fold)) (NN stimulation)) (PP (IN of) (NP (JJ LTR-mediated) (NN transcription))))))) (, ,) (IN whereas) (S (NP-SBJ (NP (ADJP (NN site) (JJ specific)) (NN mutation)) (PP (IN of) (NP (DT these) (NN GATA) (NNS sites)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ virtual) (NN abrogation)) (PP (IN of) (NP (NP (DT the) (NN activation)) (PP (IN by) (NP (NN hGATA-3))))))))) (. .))
(S (ADVP (RB Further)) (, ,) (NP-SBJ (NP (NN deletion)) (PP (IN of) (NP (DT the) (NN hGATA-3) (JJ transcriptional) (NN activation) (NN domain)))) (VP (VBD abolished) (NP (JJ GATA-dependent) (NN HIV-1) (NN trans-activation)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG showing) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN stimulation)) (PP (IN of) (NP (NP (JJ viral) (NN transcription)) (VP (VBN observed) (NP (-NONE- *)))))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ direct) (NN effect)) (PP (IN of) (NP (VBN cotransfected) (NN hGATA-3)))))))))) (. .))
(S (NP-SBJ (NP (NN Introduction)) (PP (IN of) (NP (NP (DT the) (NN HIV-1) (NNS plasmids)) (SBAR (WHPP-22 (IN in) (WHNP (WDT which))) (S (NP-SBJ-21 (DT the) (NN GATA) (NNS sites)) (VP (VBP have) (VP (VBN been) (VP (VBN mutated) (NP (-NONE- *-21)) (PP (IN into) (NP (JJ human) (NN T) (NNS lymphocytes))) (PP (-NONE- *T*-22)))))))))) (ADVP (RB also)) (VP (VBD caused) (NP (NP (DT a) (JJ significant) (NN reduction)) (PP (IN in) (NP (JJ LTR-mediated) (NN transcription)))) (PP-COOD (PP (IN at) (NP (CC both) (DT the) (JJ basal) (NN level))) (CC and) (PP (IN in) (NP (ADJP (-LRB- -LRB-) (NP-COOD (NP (NN PHA-)) (CC plus) (NP (NN PMA-))) (-RRB- -RRB-) (JJ stimulated)) (NN T) (NNS cells))))) (. .))
(S (NP-SBJ (DT These) (NNS observations)) (VP (VBP suggest) (SBAR (IN that) (S (PP (IN in) (NN addition) (TO to) (NP (NP (PRP$ its) (JJ normal) (NN role)) (PP (IN in) (NP (NN T) (NN lymphocyte) (NN gene) (NN regulation))))) (, ,) (NP-SBJ (NN hGATA-3)) (VP (MD may) (ADVP (RB also)) (VP (VB play) (NP (DT a) (JJ significant) (NN role)) (PP (IN in) (NP (NN HIV-1) (JJ transcriptional) (NN activation)))))))) (. .))
